We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+11.53%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$57.2B
AUM Growth
+$4B
Cap. Flow
-$1.18B
Cap. Flow %
-2.06%
Top 10 Hldgs %
12.48%
Holding
3,271
New
835
Increased
795
Reduced
814
Closed
718

Sector Composition

Rank Sector Weight
1 Technology 9.59%
2 Consumer Discretionary 8.82%
3 Industrials 8.12%
4 Financials 7.95%
5 Healthcare 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AX icon
2576
Axos Financial
AX
$5.48B
-27,068
Closed -$1.48M
AXTA icon
2577
Axalta
AXTA
$7.75B
-1,065,317
Closed -$34.8M
AZZ icon
2578
AZZ Inc
AZZ
$4.25B
-12,628
Closed -$734K
BALY icon
2579
Bally's
BALY
$516M
-32,376
Closed -$451K
BAP icon
2580
Credicorp
BAP
$30.1B
-19,309
Closed -$2.89M
BCRX icon
2581
BioCryst Pharmaceuticals
BCRX
$2.44B
-1,971,586
Closed -$11.8M
BCSF icon
2582
Bain Capital Specialty
BCSF
$782M
-16,472
Closed -$248K
BFLY icon
2583
Butterfly Network
BFLY
$2.54B
-42,967
Closed -$46.4K
BHF icon
2584
Brighthouse Financial
BHF
$3.01B
-56,104
Closed -$2.97M
BBT
2585
Beacon Financial Corp
BBT
$2.65B
-8,284
Closed -$206K
BHP icon
2586
BHP
BHP
$246B
-72,542
Closed -$4.96M
BHVN icon
2587
Biohaven
BHVN
$2.09B
-48,404
Closed -$2.07M
BIIB icon
2588
Biogen
BIIB
$32B
-317,302
Closed -$82.1M
BILL icon
2589
BILL Holdings
BILL
$4.76B
-6,305
Closed -$441K
BIO icon
2590
Bio-Rad Laboratories Class A
BIO
$10.2B
-15,730
Closed -$5.08M
BKE icon
2591
Buckle
BKE
$2.26B
-102,351
Closed -$4.86M
BLUE
2592
DELISTED
bluebird bio
BLUE
-1,707
Closed -$47.1K
BMRN icon
2593
CALL
BioMarin Pharmaceuticals
BMRN
$12.9B
-100,000
Closed -$9.64M
BMY icon
2594
CALL
Bristol-Myers Squibb
BMY
$137B
-9,900
Closed -$508K
BORR
2595
Borr Drilling
BORR
$1.39B
-390,260
Closed -$2.87M
BP icon
2596
CALL
BP
BP
$115B
-569,700
Closed -$20.2M
BPMC
2597
DELISTED
Blueprint Medicines
BPMC
-5,207
Closed -$480K
BRBR icon
2598
CALL
BellRing Brands
BRBR
$1.18B
-50,000
Closed -$2.77M
BRK.A icon
2599
Berkshire Hathaway Class A
BRK.A
$1.06T
-2
Closed -$1.09M
BRKR icon
2600
Bruker
BRKR
$9.07B
-262,763
Closed -$19.3M

Similar funds

Dmitry Balyasny's Q1 2024 Portfolio in Review

As of Q1 2024, Dmitry Balyasny held 3,271 positions worth $57.2B, up 7.5% from $53.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Dmitry Balyasny's Q1 2024 filing shows 835 new, 795 increased, 814 reduced and 718 closed positions. Its largest new stake was Public Service Enterprise Group: 2,419,537 shares worth $162M. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $650M.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.2% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Dmitry Balyasny's largest Q1 2024 buy was Public Service Enterprise Group: 2,419,537 shares worth $162M.
  • Dmitry Balyasny added most to Broadcom in Q1 2024, an estimated $342M increase.
  • Dmitry Balyasny's biggest Q1 2024 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $650M.
  • Dmitry Balyasny fully exited Splunk Inc in Q1 2024, selling an estimated $263M.
  • Dmitry Balyasny's ten largest holdings make up 12% of its $57.2B portfolio in Q1 2024.
  • Dmitry Balyasny opened 835 new positions and closed 718 in Q1 2024.
  • Dmitry Balyasny's portfolio value rose 7.5% quarter-over-quarter to $57.2B.

Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.